Hormonal Outcomes in Acromegalic Patients With Treated Surgery With or Without Long Acting Somatostatin Analogues
Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
Long-term (up to 3 years) clinical and hormonal outcomes in acromegalic patients with treated
surgery with or without long acting somatostatin analogues.